- What A group of investors has bought a former pharmaceutical plant in Québec City for $17m, Le Journal de Montréal reported
- Why The site will be redeveloped into a life-science hub
- What next Construction will commence in 2025
A group of investors has purchased the former Medicago complex in the Québec City suburb of Beauport for $17m, Le Journal de Montréal reported last week.
A partnership led by HarveyCorp president Hugues Harvey and Anapharm founder Marc LeBel acquired the 700,000 sq ft property, at 2300 D’Estimauville Avenue.
The plant, built in 2015, was among several properties previously owned by the Québec City-based pharmaceutical company. The company’s Japan-based parent, Mitsubishi Chemical Group, shut down its operations in February 2023.
The deal completes the sale of Medicago’s remaining assets in the area.
The property will be redeveloped into a life-science hub in 2025. Tenants are expected to enter the facility in 2026.
